Articles published by Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock
February 20, 2024
Via GlobeNewswire
Tickers
IOVA

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 16, 2024
Via GlobeNewswire
Tickers
IOVA

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024
February 16, 2024
Via GlobeNewswire
Tickers
IOVA

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
February 16, 2024
Via GlobeNewswire
Tickers
IOVA

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
January 19, 2024
Via GlobeNewswire
Tickers
IOVA

Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer
December 27, 2023
Via GlobeNewswire
Tickers
IOVA

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
December 22, 2023
Via GlobeNewswire
Tickers
IOVA

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
November 17, 2023
Via GlobeNewswire
Tickers
IOVA




Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
October 20, 2023
Via GlobeNewswire
Tickers
IOVA



Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
September 22, 2023
Via GlobeNewswire
Tickers
IOVA


Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference
September 07, 2023
Via GlobeNewswire
Tickers
IOVA

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 18, 2023
Via GlobeNewswire
Tickers
IOVA




Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 21, 2023
Via GlobeNewswire
Tickers
IOVA

Iovance Biotherapeutics Announces Closing of $172.5 Million Common Stock Public Offering
July 13, 2023
Via GlobeNewswire
Tickers
IOVA


Via GlobeNewswire
Tickers
IOVA



Via GlobeNewswire
Tickers
IOVA

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.